Evaluation of 4D Intracardiac Echocardiography (ICE) During Structural Heart and Electrophysiology Procedures
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT07806890
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 4D ICE Adjunct Imaging — DEVICEUse of investigational 4D ICE catheter for real-time intracardiac imaging during cardiac interventional procedures, performed adjunctively to standard-of-care TEE guidance.
Study Details
The purpose of this study is to evaluate the imaging performance and procedural safety of a prototype 4D ICE catheter during real-time intracardiac imaging and to optimize device imaging parameters, compared with current standard imaging modalities. TEE is the current standard of care and will serve as the primary imaging modality for clinical guidance during the EP and Structural Heart Disease (SHD) procedures. In this research protocol, TEE is not being investigated. ICE will be used as an adjunct imaging modality for research data collection and workflow evaluation only. All procedures will be performed using commercially available, FDA-approved Watchman devices, and no investigational implantable devices will be used. The use of ICE in this study does not modify the approved therapeutic device indication, implantation technique, or standard clinical decision-making.
Key Dates
- First listed
- Sep 8, 2026
- Start date
- Aug 7, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: 4D ICE Adjunct ImagingParticipants undergoing left atrial appendage occlusion (LAAO) procedures (with or without concomitant electrophysiology procedures) will receive adjunctive imaging using the 4D ICE catheter while TEE remains the primary imaging modality for procedural guidance.
Primary Outcome Measure
Feasibility of 4D ICE Imaging Performance [ Time Frame: During the Procedure ]
Central Contacts
- Walid Saliba, MD216-444-6810
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinical Foundation | Cleveland | Ohio | 44195 | Oussama Wazni, MD (SUB_INVESTIGATOR) |
Find similar trials in Cleveland, OH
Related Studies
- High-resolution MRI of Atrial Fibrillation Patients Prior to Focal Impulse and Rotor Modulation (FIRM) AblationRecruiting · Ohio State University · Columbus, Ohio
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Tracking Results of Ablations to Combat AF Registry Generation 2Recruiting · AtriCure, Inc. · Huntsville, Alabama